DURHAM, N.C., Jan. 28, 2013 (GLOBE NEWSWIRE) -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced today its Chief Operating Officer and Vice President of Manufacturing, Dr. Frederick Miesowicz, will present during two focus sessions at Phacilitate's 9th Annual Cell and Gene Therapy Forum on January 28 and 29 in Washington, D.C.
